Glucocorticoids and the innate immune system: Crosstalk with the Toll-like receptor signaling network

Molecular and Cellular Endocrinology

Volumn 275, Issue 1-2, 2007, Pages 30-42

  Chinenov, Yurii ^a   Rogatsky, Inez ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Glucocorticoid receptor; Innate immunity and inflammation; Interferon regulatory factors; Toll like receptors; Transcriptional regulation

Indexed keywords

GLUCOCORTICOID RECEPTOR; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; DNA BINDING; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; GLUCOCORTICOIDS; HUMANS; IMMUNITY, NATURAL; RECEPTOR CROSS-TALK; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC;

EID: 34547902854     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.04.014     Document Type: Article

References (151)

1. Abraham S.M., and Clark A.R. Dual-specificity phosphatase. 1. A critical regulator of innate immune responses. Biochem. Soc. Trans. 34 (2006) 1018-1023
2. Abraham S.M., Lawrence T., Kleiman A., Warden P., Medghalchi M., Tuckermann J., Saklatvala J., and Clark A.R. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203 (2006) 1883-1889
3. Alexander W.S., and Hilton D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22 (2004) 503-529
4. Asselin-Labat M.L., David M., Biola-Vidamment A., Lecoeuche D., Zennaro M.C., Bertoglio J., and Pallardy M. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 104 (2004) 215-223
5. Asselin-Labat M.L., Biola-Vidamment A., Kerbrat S., Lombes M., Bertoglio J., and Pallardy M. FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol. Endocrinol. 19 (2005) 1752-1764
6. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (1995) 286-290
7. Ayroldi E., Migliorati G., Bruscoli S., Marchetti C., Zollo O., Cannarile L., D'Adamio F., and Riccardi C. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98 (2001) 743-753
8. Ayroldi E., Zollo O., Macchiarulo A., Di Marco B., Marchetti C., and Riccardi C. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol. Cell. Biol. 22 (2002) 7929-7941
9. Baetz A., Frey M., Heeg K., and Dalpke A.H. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279 (2004) 54708-54715
10. Batsche E., Desroches J., Bilodeau S., Gauthier Y., and Drouin J. Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J. Biol. Chem. 280 (2005) 19746-19756
11. Belandia B., Orford R.L., Hurst H.C., and Parker M.G. Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J. 21 (2002) 4094-4103
12. Bell J.K., Mullen G.E., Leifer C.A., Mazzoni A., Davies D.R., and Segal D.M. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24 (2003) 528-533
13. Bell J.K., Botos I., Hall P.R., Askins J., Shiloach J., Segal D.M., and Davies D.R. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 10976-10980
14. Bell J.K., Askins J., Hall P.R., Davies D.R., and Segal D.M. The dsRNA binding site of human Toll-like receptor 3. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8792-8797
15. Berrebi D., Bruscoli S., Cohen N., Foussat A., Migliorati G., Bouchet-Delbos L., Maillot M.C., Portier A., Couderc J., Galanaud P., Peuchmaur M., Riccardi C., and Emilie D. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101 (2003) 729-738
16. Bornstein S.R., Schumann R.R., Rettori V., McCann S.M., and Zacharowski K. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals. Horm. Metab. Res. 36 (2004) 470-473
17. Bornstein S.R., Zacharowski P., Schumann R.R., Barthel A., Tran N., Papewalis C., Rettori V., McCann S.M., Schulze-Osthoff K., Scherbaum W.A., Tarnow J., and Zacharowski K. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16695-16700
18. Brass A.L., Zhu A.Q., and Singh H. Assembly requirements of PU. 1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimmers. EMBO J. 18 (1999) 977-991
19. Caelles C., Gonzalez-Sancho J.M., and Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11 (1997) 3351-3364
20. Cannarile L., Zollo O., D'Adamio F., Ayroldi E., Marchetti C., Tabilio A., Bruscoli S., and Riccardi C. Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ. 8 (2001) 201-203
21. Charron J., and Drouin J. Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 8903-8907
22. Chauhan S., Leach C.H., Kunz S., Bloom J.W., and Miesfeld R.L. Glucocorticoid regulation of human eosinophil gene expression. J. Steroid Biochem. Mol. Biol. 84 (2003) 441-452
23. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., and Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 284 (1999) 2174-2177
24. Chen S.L., Dowhan D.H., Hosking B.M., and Muscat G.E. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14 (2000) 1209-1228
25. Chen Y.H., Kim J.H., and Stallcup M.R. GAC63, a GRIP1-dependent nuclear receptor coactivator. Mol. Cell. Biol. 25 (2005) 5965-5972
26. Chen W., Rogatsky I., and Garabedian M.J. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol. Endocrinol. 20 (2006) 560-572
27. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., and Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2274-2279
28. Choe J., Kelker M.S., and Wilson I.A. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309 (2005) 581-585
29. Coghlan M.J., Jacobson P.B., Lane B., Nakane M., Lin C.W., Elmore S.W., Kym P.R., Luly J.R., Carter G.W., Turner R., Tyree C.M., Hu J., Elgort M., Rosen J., and Miner J.N. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 17 (2003) 860-869
30. Crooks G.E., Hon G., Chandonia J.M., and Brenner S.E. WebLogo: a sequence logo generator. Genome Res. 14 (2004) 1188-1190
31. D'Adamio F., Zollo O., Moraca R., Ayroldi E., Bruscoli S., Bartoli A., Cannarile L., Migliorati G., and Riccardi C. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7 (1997) 803-812
32. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
33. De Bosscher K., Vanden Berghe W., and Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24 (2003) 488-522
34. De Bosscher K., Vanden Berghe W., and Haegeman G. Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25 (2006) 6868-6886
35. DeFranco D.B. Regulation of steroid receptor subcellular trafficking. Cell. Biochem. Biophys. 30 (1999) 1-24
36. Delfino D.V., Agostini M., Spinicelli S., Vito P., and Riccardi C. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 104 (2004) 4134-4141
37. Diamond M.I., Miner J.N., Yoshinaga S.K., and Yamamoto K.R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249 (1990) 1266-1272
38. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., Rao G., Sun R., Haberland M., Modlin R., and Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17 (2002) 251-263
39. Eddleston J., Herschbach J., Wagelie-Steffen A.L., Christiansen S.C., and Zuraw B.L. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J. Allergy Clin. Immunol. 119 (2007) 115-122
40. Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., Sonderegger I., Bachmaier K., Kopf M., and Penninger J.M. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9 (2003) 1484-1490
41. Eroshkin A., and Mushegian A. Conserved transactivation domain shared by interferon regulatory factors and Smad morphogens. J. Mol. Med. 77 (1999) 403-405
42. Escalante C.R., Yie J., Thanos D., and Aggarwal A.K. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 391 (1998) 103-106
43. Escalante C.R., Brass A.L., Pongubala J.M., Shatova E., Shen L., Singh H., and Aggarwal A.K. Crystal structure of PU. 1/IRF-4/DNA ternary complex. Mol. Cell. 10 (2002) 1097-1105
44. Faure E., Thomas L., Xu H., Medvedev A., Equils O., and Arditi M. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J. Immunol. 166 (2001) 2018-2024
45. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., and Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 (2003) 491-496
46. Fujii Y., Shimizu T., Kusumoto M., Kyogoku Y., Taniguchi T., and Hakoshima T. Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J. 18 (1999) 5028-5041
47. Furst R., Schroeder T., Eilken H.M., Bubik M.F., Kiemer A.K., Zahler S., and Vollmar A.M. MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J. 21 (2007) 74-80
48. Germain P., Altucci L., Bourguet W., Rochette-Egly C., and Gronemeyer H. Nuclear receptor superfamily: principles of signaling. Pure Appl. Chem. 75 (2003) 1619-1664
49. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3 (2004) 950-964
50. Hammer M., Mages J., Dietrich H., Servatius A., Howells N., Cato A.C., and Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203 (2006) 15-20
51. Harii N., Lewis C.J., Vasko V., McCall K., Benavides-Peralta U., Sun X., Ringel M.D., Saji M., Giuliani C., Napolitano G., Goetz D.J., and Kohn L.D. Thyrocytes express a functional Toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with hashimoto's autoimmune thyroiditis. Mol. Endocrinol. 19 (2005) 1231-1250
52. Heery D.M., Kalkhoven E., Hoare S., and Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 (1997) 733-736
53. Hemmi H., Takeuchi O., Sato S., Yamamoto M., Kaisho T., Sanjo H., Kawai T., Hoshino K., Takeda K., and Akira S. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199 (2004) 1641-1650
54. Hench P.S., Kendall E.C., Slocumb C.H., and Polley H.F. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch. Med. Int. 85 (1950) 545-666
55. Hermoso M.A., Matsuguchi T., Smoak K., and Cidlowski J.A. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate Toll-like receptor 2 gene expression. Mol. Cell. Biol. 24 (2004) 4743-4756
56. Hirasawa N., Sato Y., Fujita Y., Mue S., and Ohuchi K. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. J. Immunol. 161 (1998) 4939-4943
57. Homma T., Kato A., Hashimoto N., Batchelor J., Yoshikawa M., Imai S., Wakiguchi H., Saito H., and Matsumoto K. Corticosteroid and cytokines synergistically enhance Toll-like receptor 2 expression in respiratory epithelial cells. Am. J. Respir. Cell. Mol. Biol. 31 (2004) 463-469
58. Honda K., and Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6 (2006) 644-658
59. Hoshino K., Sugiyama T., Matsumoto M., Tanaka T., Saito M., Hemmi H., Ohara O., Akira S., and Kaisho T. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440 (2006) 949-953
60. Imasato A., Desbois-Mouthon C., Han J., Kai H., Cato A.C., Akira S., and Li J.D. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of Toll-like receptor 2. J. Biol. Chem. 277 (2002) 47444-47450
61. Itani O.A., Auerbach S.D., Husted R.F., Volk K.A., Ageloff S., Knepper M.A., Stokes J.B., and Thomas C.P. Glucocorticoid-stimulated lung epithelial Na(+) transport is associated with regulated ENaC and sgk1 expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 282 (2002) L631-L641
62. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., and Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62 (1990) 1189-1204
63. Kagan J.C., and Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125 (2006) 943-955
64. A gene. Nature 308 (1984) 513-519
65. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., and Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20 (2001) 7108-7116
66. Kewley R.J., Whitelaw M.L., and Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell. Biol. 36 (2004) 189-204
67. Kim J.H., Li H., and Stallcup M.R. CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. Mol. Cell. 12 (2003) 1537-1549
68. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., and Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17 (2002) 583-591
69. Le Douarin B., Nielsen A.L., Garnier J.M., Ichinose H., Jeanmougin F., Losson R., and Chambon P. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15 (1996) 6701-6715
70. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
71. Lee Y.H., Koh S.S., Zhang X., Cheng X., and Stallcup M.R. Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities. Mol. Cell. Biol. 22 (2002) 3621-3632
72. Lee Y.H., Campbell H.D., and Stallcup M.R. Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity. Mol. Cell. Biol. 24 (2004) 2103-2117
73. Lee Y.H., Coonrod S.A., Kraus W.L., Jelinek M.A., and Stallcup M.R. Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 3611-3616
74. Lefstin J.A., and Yamamoto K.R. Allosteric effects of DNA on transcriptional regulators. Nature 392 (1998) 885-888
75. Lerner L., Henriksen M.A., Zhang X., and Darnell Jr. J.E. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 17 (2003) 2564-2577
76. Lewis E.J., Harrington C.A., and Chikaraishi D.M. Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3550-3554
77. Lin R., and Hiscott J. A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity. Mol. Cell. Biochem. 191 (1999) 169-180
78. Lin R., Yang L., Arguello M., Penafuerte C., and Hiscott J. A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J. Biol. Chem. 280 (2005) 3088-3095
79. Liu S., Salyapongse A.N., Geller D.A., Vodovotz Y., and Billiar T.R. Hepatocyte Toll-like receptor 2 expression in vivo and in vitro: role of cytokines in induction of rat TLR2 gene expression by lipopolysaccharide. Shock 14 (2000) 361-365
80. Liu Y., Wang Y., Yamakuchi M., Isowaki S., Nagata E., Kanmura Y., Kitajima I., and Maruyama I. Upregulation of Toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation. Infect. Immun. 69 (2001) 2788-2796
81. Louie M.C., Zou J.X., Rabinovich A., and Chen H.W. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol. Cell. Biol. 24 (2004) 5157-5171
82. Mansell A., Smith R., Doyle S.L., Gray P., Fenner J.E., Crack P.J., Nicholson S.E., Hilton D.J., O'Neill L.A., and Hertzog P.J. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7 (2006) 148-155
83. Marco B.D., Massetti M., Bruscoli S., Macchiarulo A., Virgilio R.D., Velardi E., Donato V., Migliorati G., and Riccardi C. Glucocorticoid-induced leucine zipper (GILZ)/NF-{kappa}B interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res. 35 (2007) 517-528
84. McWhirter S.M., Fitzgerald K.A., Rosains J., Rowe D.C., Golenbock D.T., and Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 233-238
85. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., and Tschopp J. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5 (2004) 503-507
86. Miner J.N., and Yamamoto K.R. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev. 6 (1992) 2491-2501
87. Mittelstadt P.R., and Ashwell J.D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276 (2001) 29603-29610
88. Na S.Y., Lee S.K., Han S.J., Choi H.S., Im S.Y., and Lee J.W. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations. J. Biol. Chem. 273 (1998) 10831-10834
89. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., Akira S., Yamanishi K., Kawase I., Nakanishi K., and Kishimoto T. SOCS-1 participates in negative regulation of LPS responses. Immunity 17 (2002) 677-687
90. Nissen R.M., and Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14 (2000) 2314-2329
91. Nordeen S.K., Suh B.J., Kuhnel B., and Hutchison C.D. Structural determinants of a glucocorticoid receptor recognition element. Mol. Endocrinol. 4 (1990) 1866-1873
92. Oda K., and Kitano H. A comprehensive map of the Toll-like receptor signaling network. Mol. Syst. Biol. 2 (2006) 0015
93. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., and Glass C.K. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122 (2005) 707-721
94. Panne D., Maniatis T., and Harrison S.C. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J. 23 (2004) 4384-4393
95. Perissi V., and Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell. Biol. 6 (2005) 542-554
96. Qin B.Y., Liu C., Lam S.S., Srinath H., Delston R., Correia J.J., Derynck R., and Lin K. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 10 (2003) 913-921
97. Qin B.Y., Liu C., Srinath H., Lam S.S., Correia J.J., Derynck R., and Lin K. Crystal structure of IRF-3 in complex with CBP. Structure 13 (2005) 1269-1277
98. Reichardt H.M., Tuckermann J.P., Gottlicher M., Vujic M., Weih F., Angel P., Herrlich P., and Schutz G. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20 (2001) 7168-7173
99. Reichstein T. Chemistry of adrenal cortex hormones. Bull. Schweiz. Akad. Med. Wiss. 7 (1951) 359-370
100. Reily M.M., Pantoja C., Hu X., Chinenov Y., and Rogatsky I. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 25 (2006) 108-117
101. Rogatsky I., and Ivashkiv L.B. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 68 (2006) 1-12
102. Rogatsky I., Zarember K.A., and Yamamoto K.R. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. 20 (2001) 6071-6083
103. Rogatsky I., Luecke H.F., Leitman D.C., and Yamamoto K.R. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16701-16706
104. Rogatsky I., Wang J.C., Derynck M.K., Nonaka D.F., Khodabakhsh D.B., Haqq C.M., Darimont B.D., Garabedian M.J., and Yamamoto K.R. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13845-13850
105. Rosenfeld M.G., Lunyak V.V., and Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20 (2006) 1405-1428
106. Rowe D.C., McGettrick A.F., Latz E., Monks B.G., Gay N.J., Yamamoto M., Akira S., O'Neill L.A., Fitzgerald K.A., and Golenbock D.T. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6299-6304
107. Rozansky D.J., Wu H., Tang K., Parmer R.J., and O'Connor D.T. Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element. J. Clin. Invest. 94 (1994) 2357-2368
108. Rozkova D., Horvath R., Bartunkova J., and Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin. Immunol. 120 (2006) 260-271
109. Sakai A., Han J., Cato A.C., Akira S., and Li J.D. Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol. Biol. 5 (2004) 2
110. Salojin K.V., Owusu I.B., Millerchip K.A., Potter M., Platt K.A., and Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176 (2006) 1899-1907
111. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6 (2005) 1087-1095
112. Savkur R.S., and Burris T.P. The coactivator LXXLL nuclear receptor recognition motif. J. Pept. Res. 63 (2004) 207-212
113. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin Jr. A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283-286
114. Schmidt S., Rainer J., Riml S., Ploner C., Jesacher S., Achmuller C., Presul E., Skvortsov S., Crazzolara R., Fiegl M., Raivio T., Janne O.A., Geley S., Meister B., and Kofler R. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 107 (2006) 2061-2069
115. Schneider T.D., and Stephens R.M. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18 (1990) 6097-6100
116. Schoenemeyer A., Barnes B.J., Mancl M.E., Latz E., Goutagny N., Pitha P.M., Fitzgerald K.A., and Golenbock D.T. The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J. Biol. Chem. 280 (2005) 17005-17012
117. Shim J.H., Xiao C., Paschal A.E., Bailey S.T., Rao P., Hayden M.S., Lee K.Y., Bussey C., Steckel M., Tanaka N., Yamada G., Akira S., Matsumoto K., and Ghosh S. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19 (2005) 2668-2681
118. Shuto T., Imasato A., Jono H., Sakai A., Xu H., Watanabe T., Rixter D.D., Kai H., Andalibi A., Linthicum F., Guan Y.L., Han J., Cato A.C., Lim D.J., Akira S., and Li J.D. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277 (2002) 17263-17270
119. So A.Y.-L., Chaivorapol C., Bolton E.C., Li H., and Yamamoto K.R. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLOS Genet. 3 (2007) e94 10.1371/journal.pgen.0030094
120. Stocklin E., Wissler M., Gouilleux F., and Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383 (1996) 726-728
121. Stoecklin E., Wissler M., Moriggl R., and Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol. Cell. Biol. 17 (1997) 6708-6716
122. Strahle U., Klock G., and Schutz G. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7871-7875
123. Stromstedt P.E., Poellinger L., Gustafsson J.A., and Carlstedt-Duke J. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol. Cell. Biol. 11 (1991) 3379-3383
124. Takahasi K., Suzuki N.N., Horiuchi M., Mori M., Suhara W., Okabe Y., Fukuhara Y., Terasawa H., Akira S., Fujita T., and Inagaki F. X-ray crystal structure of IRF-3 and its functional implications. Nat. Struct. Biol. 10 (2003) 922-927
125. Tamura T., and Ozato K. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interf. Cytokine Res. 22 (2002) 145-152
126. Tanaka N., Kawakami T., and Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13 (1993) 4531-4538
127. tenOever B.R., Sharma S., Zou W., Sun Q., Grandvaux N., Julkunen I., Hemmi H., Yamamoto M., Akira S., Yeh W.C., Lin R., and Hiscott J. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J. Virol. 78 (2004) 10636-10649
128. Thanos D., and Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83 (1995) 1091-1100
129. Tonko M., Ausserlechner M.J., Bernhard D., Helmberg A., and Kofler R. Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J. 15 (2001) 693-699
130. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., and Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387 (1997) 677-684
131. Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F., Matsuda M., Coban C., Ishii K.J., Kawai T., Takeuchi O., and Akira S. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 201 (2005) 915-923
132. Vakharia K., and Hinson J.P. Lipopolysaccharide directly stimulates cortisol secretion by human adrenal cells by a cyclooxygenase-dependent mechanism. Endocrinology 146 (2005) 1398-1402
133. Vakharia K., Renshaw D., and Hinson J.P. Bacterial lipopolysaccharide directly stimulates cortisol secretion in human adrenal cells. Endocr. Res. 28 (2002) 357-361
134. Veals S.A., Santa Maria T., and Levy D.E. Two domains of ISGF3 gamma that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell. Biol. 13 (1993) 196-206
135. Voegel J.J., Heine M.J., Tini M., Vivat V., Chambon P., and Gronemeyer H. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17 (1998) 507-519
136. Wang J.C., Derynck M.K., Nonaka D.F., Khodabakhsh D.B., Haqq C., and Yamamoto K.R. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15603-15608
137. Webster M.K., Goya L., Ge Y., Maiyar A.C., and Firestone G.L. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol. Cell. Biol. 13 (1993) 2031-2040
138. West A.P., Koblansky A.A., and Ghosh S. Recognition and signaling by Toll-like receptors. Annu. Rev. Cell. Dev. Biol. 22 (2006) 409-437
139. Wietek C., Miggin S.M., Jefferies C.A., and O'Neill L.A. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278 (2003) 50923-50931
140. Wu J.W., Krawitz A.R., Chai J., Li W., Zhang F., Luo K., and Shi Y. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell 111 (2002) 357-367
141. Wu H.Y., Hamamori Y., Xu J., Chang S.C., Saluna T., Chang M.F., O'Malley B.W., and Kedes L. Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD. J. Biol. Chem. 280 (2005) 3129-3137
142. Xu J., and O'Malley B.W. Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function. Rev. Endocr. Metab. Disord. 3 (2002) 185-192
143. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., and Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408 (2000) 111-115
144. Yamamoto K.R., Darimont B.D., Wagner R.L., and Iniguez-Lluhi J.A. Building transcriptional regulatory complexes: signals and surfaces. Cold Spring Harb Symp Quant Biol 63 (1998) 587-598
145. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., and Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169 (2002) 6668-6672
146. Yang-Yen H.-F., Chambard J.-C., Sun Y.-L., Smeal T., Schmidt T.J., Drouin J., and Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62 (1990) 1205-1215
147. Yoshida N.L., Miyashita T.U.M., Yamada M., Reed J.C., Sugita Y., and Oshida T. Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem. Biophys. Res. Commun. 293 (2002) 1254-1261
148. Zacharowski K., Zacharowski P.A., Koch A., Baban A., Tran N., Berkels R., Papewalis C., Schulze-Osthoff K., Knuefermann P., Zahringer U., Schumann R.R., Rettori V., McCann S.M., and Bornstein S.R. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6392-6397
149. Zhang Z., Jones S., Hagood J.S., Fuentes N.L., and Fuller G.M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 272 (1997) 30607-30610
150. Zhang Y., Blattman J.N., Kennedy N.J., Duong J., Nguyen T., Wang Y., Davis R.J., Greenberg P.D., Flavell R.A., and Dong C. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430 (2004) 793-797
151. Zhao Q., Wang X., Nelin L.D., Yao Y., Matta R., Manson M.E., Baliga R.S., Meng X., Smith C.V., Bauer J.A., Chang C.H., and Liu Y. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203 (2006) 131-140